S&P 500 7,376.86 +0.31%
Nasdaq 24,579.42 +1.09%
S&P/TSX 35,789.09 +0.52%
Apple 342.37 −0.52%
Nvidia 186.64 +2.78%
Microsoft 530.61 −0.99%
Shopify 210.47 +4.59%
Royal Bank 284.16 −0.59%
CAD/USD 0.7094 −0.56%
PRE-MKT · 07:40 ET
Market ClerkRecap
Mon Nov 9 · pre-market1 signal today226 insider buys this week · $429.6MCIRO short report next: Nov 15The week ahead
TV
INSIDER · OTLC · Oncotelic Therapeutics, Inc. · CHAIRMAN AND CEO

Trieu Vuong

Every open-market transaction filed under this name, Oct 28 to Oct 29.

Filings
2
2 buys · 0 sells
Bought
$24K
open market, at cost
Sold
—
includes scheduled sales
Buys since
−14.2%
avg move from buy price, 2 priced

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Oct 29OTLCOncotelic Therapeutics, Inc.CHAIRMAN AND CEOBuy1,044,990$0.02$18K−10.6%
Oct 28OTLCOncotelic Therapeutics, Inc.CHAIRMAN AND CEOBuy312,000$0.02$6K−17.8%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.